Total Payments
$101,319
2024 Payments
$52.10
Companies
10
Transactions
76
Medicare Patients
1,121
Medicare Billing
$221,678
Payment Breakdown by Category
Other$77,110 (76.1%)
Consulting$14,425 (14.2%)
Travel$7,629 (7.5%)
Food & Beverage$2,032 (2.0%)
Education$122.51 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $74,110 | 31 | 73.1% |
| Consulting Fee | $14,425 | 3 | 14.2% |
| Travel and Lodging | $7,629 | 16 | 7.5% |
| Honoraria | $3,000 | 1 | 3.0% |
| Food and Beverage | $2,032 | 22 | 2.0% |
| Education | $122.51 | 3 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Seattle Genetics, Inc. | $60,655 | 39 | $0 (2019) |
| Seagen Inc. | $27,407 | 18 | $0 (2021) |
| Genentech USA, Inc. | $6,621 | 6 | $0 (2018) |
| ABBVIE INC. | $5,322 | 7 | $0 (2024) |
| Celgene Corporation | $750.00 | 1 | $0 (2019) |
| Epizyme, Inc., | $395.00 | 1 | $0 (2022) |
| Pharmacyclics LLC, An AbbVie Company | $99.00 | 1 | $0 (2017) |
| Balt USA, LLC | $29.96 | 1 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $24.77 | 1 | $0 (2018) |
| Incyte Corporation | $15.66 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $52.10 | 1 | ABBVIE INC. ($52.10) |
| 2022 | $395.00 | 1 | Epizyme, Inc., ($395.00) |
| 2021 | $12,863 | 9 | Seagen Inc. ($12,863) |
| 2020 | $14,574 | 10 | Seagen Inc. ($14,544) |
| 2019 | $26,832 | 17 | Seattle Genetics, Inc. ($26,060) |
| 2018 | $34,265 | 26 | Seattle Genetics, Inc. ($27,620) |
| 2017 | $12,338 | 12 | Seattle Genetics, Inc. ($6,975) |
All Payment Transactions
76 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/29/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $52.10 | General |
| 03/09/2022 | Epizyme, Inc., | TAZVERIK (Drug) | Food and Beverage | In-kind items and services | $395.00 | General |
| Category: ONCOLOGY | ||||||
| 02/12/2021 | Seagen Inc. | ADCETRIS (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,500.00 | General |
| Category: Oncology | ||||||
| 02/12/2021 | Seagen Inc. | ADCETRIS (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,500.00 | General |
| Category: Oncology | ||||||
| 02/12/2021 | Seagen Inc. | ADCETRIS (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,440.00 | General |
| Category: Oncology | ||||||
| 02/10/2021 | Seagen Inc. | ADCETRIS (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,850.00 | General |
| Category: Oncology | ||||||
| 01/21/2021 | Seagen Inc. | ADCETRIS (Biological) | Food and Beverage | In-kind items and services | $49.66 | General |
| Category: Oncology | ||||||
| 01/21/2021 | Seagen Inc. | ADCETRIS (Biological) | Food and Beverage | In-kind items and services | $27.51 | General |
| Category: Oncology | ||||||
| 01/21/2021 | Seagen Inc. | ADCETRIS (Biological) | Food and Beverage | In-kind items and services | $26.00 | General |
| Category: Oncology | ||||||
| 01/15/2021 | Seagen Inc. | ADCETRIS (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,235.00 | General |
| Category: Oncology | ||||||
| 01/12/2021 | Seagen Inc. | ADCETRIS (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,235.00 | General |
| Category: Oncology | ||||||
| 11/20/2020 | Seagen Inc. | ADCETRIS (Biological) | Consulting Fee | Cash or cash equivalent | $1,925.00 | General |
| Category: Oncology | ||||||
| 09/07/2020 | Seagen Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $920.00 | General |
| 09/02/2020 | Seagen Inc. | ADCETRIS (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,235.00 | General |
| Category: Oncology | ||||||
| 06/12/2020 | Seagen Inc. | ADCETRIS (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $690.00 | General |
| Category: Oncology | ||||||
| 06/05/2020 | Seagen Inc. | ADCETRIS (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $920.00 | General |
| Category: Oncology | ||||||
| 03/12/2020 | Seagen Inc. | ADCETRIS (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,945.00 | General |
| Category: Oncology | ||||||
| 03/10/2020 | Seagen Inc. | ADCETRIS (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,945.00 | General |
| Category: Oncology | ||||||
| 03/05/2020 | Seagen Inc. | ADCETRIS (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,945.00 | General |
| Category: Oncology | ||||||
| 03/05/2020 | Seagen Inc. | ADCETRIS (Biological) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: Oncology | ||||||
| 03/04/2020 | Balt USA, LLC | Ballast (Device), MAGIC Catheter, Optima Thermal Coil System | Food and Beverage | In-kind items and services | $29.96 | General |
| Category: Neurology | ||||||
| 11/26/2019 | Seattle Genetics, Inc. | ADCETRIS (Biological) | Consulting Fee | Cash or cash equivalent | $6,900.00 | General |
| Category: Oncology | ||||||
| 09/27/2019 | Seattle Genetics, Inc. | ADCETRIS (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,500.00 | General |
| Category: Oncology | ||||||
| 09/27/2019 | Seattle Genetics, Inc. | ADCETRIS (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,500.00 | General |
| Category: Oncology | ||||||
| 09/13/2019 | Seattle Genetics, Inc. | ADCETRIS (Biological) | Travel and Lodging | In-kind items and services | $291.23 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 138 | 154 | $70,558 | $8,133 |
| 2022 | 5 | 375 | 772 | $353,200 | $69,122 |
| 2021 | 5 | 293 | 786 | $366,643 | $77,384 |
| 2020 | 6 | 315 | 818 | $217,347 | $67,039 |
Total Patients
1,121
Total Services
2,530
Medicare Billing
$221,678
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 110 | 120 | $49,920 | $5,573 | 11.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 28 | 34 | $20,638 | $2,559 | 12.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 241 | 404 | $168,064 | $29,419 | 17.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 73 | 210 | $127,470 | $24,110 | 18.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 26 | 122 | $33,226 | $10,271 | 30.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 20 | 20 | $15,160 | $2,826 | 18.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 15 | 16 | $9,280 | $2,495 | 26.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 65 | 277 | $167,501 | $33,508 | 20.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 152 | 304 | $125,022 | $22,465 | 18.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 29 | 156 | $40,716 | $13,443 | 33.0% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 28 | 28 | $21,224 | $4,507 | 21.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 19 | 21 | $12,180 | $3,460 | 28.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 43 | 235 | $61,335 | $20,834 | 34.0% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 53 | 215 | $61,920 | $19,771 | 31.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 153 | 298 | $61,033 | $16,991 | 27.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 24 | 27 | $15,660 | $4,200 | 26.8% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 31 | 31 | $13,919 | $4,155 | 29.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 11 | 12 | $3,480 | $1,088 | 31.3% |
About Scott Smith, MD PHD
Scott Smith, MD PHD is a Hematology & Oncology healthcare provider based in Maywood, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/28/2005. The National Provider Identifier (NPI) number assigned to this provider is 1215914494.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Scott Smith, MD PHD has received a total of $101,319 in payments from pharmaceutical and medical device companies, with $52.10 received in 2024. These payments were reported across 76 transactions from 10 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($74,110).
As a Medicare-enrolled provider, Smith has provided services to 1,121 Medicare beneficiaries, totaling 2,530 services with total Medicare billing of $221,678. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Maywood, IL
- Active Since 12/28/2005
- Last Updated 01/28/2022
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1215914494
Products in Payments
- ADCETRIS (Biological) $78,062
- SGN35 (Biological) $6,967
- Rituxan (Biological) $6,621
- Venclexta (Drug) $5,248
- Adcetris (Biological) $2,112
- Revlimid (Drug) $750.00
- TAZVERIK (Drug) $395.00
- Imbruvica (Drug) $99.00
- Ballast (Device) $29.96
- XARELTO (Drug) $24.77
- JAKAFI (Drug) $15.66
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Maywood
Mohamad Khair Khasawneh, Md, MD
Hematology & Oncology — Payments: $1.1M
Hematology & Oncology $1.1M
Dr. Stephanie Tsai, M.d, M.D
Hematology & Oncology — Payments: $141,544
Hematology & Oncology $141,544
Agne Paner, M.d, M.D
Hematology & Oncology — Payments: $131,263
Hematology & Oncology $131,263
Patrick Hagen, M.d., M.p.h, M.D., M.P.H
Hematology & Oncology — Payments: $118,454
Hematology & Oncology $118,454
Joseph Clark, Md, MD
Hematology & Oncology — Payments: $102,053
Hematology & Oncology $102,053
Patrick Stiff, Md, MD
Hematology & Oncology — Payments: $28,293
Hematology & Oncology $28,293